Molecular Beacon Probes for Rifampicin-Resistant TB Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting Rifampicin-resistant Mycobacterium tuberculosis are cumbersome and lack high sensitivity and specificity, particularly due to the open hybridization format of existing assays which require rigorous separation of work areas and numerous probes, limiting their use in high-throughput testing.
Innovation Solution
The development of molecular beacon probes that are at least 85% identical to specific nucleic acid sequences, used for amplifying and probing the Rifampicin Resistance Determining Region (RRDR) of the rpoB gene, allowing for melting temperature analysis to detect Rifampicin-resistant strains in a closed system, thereby simplifying the testing process and minimizing cross-contamination.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If open hybridization format assays are used for Rifampicin-resistance screening, then detection capability is achieved, but device complexity and ease of operation deteriorate due to requiring rigorous separation of work areas and numerous probes
Solution Approach 1:
The patent combines multiple probe functions into a single closed-tube PCR system. Molecular beacon probes are designed with specific stem-loop structures that allow them to detect multiple resistance mutations simultaneously within a single reaction vessel, eliminating the need for separate work areas and reducing the number of individual probes required compared to open hybridization systems.
Solution Approach 2:
The molecular beacon probes act as intermediaries that bridge the detection of multiple mutations within a single PCR reaction. The probes' stem-loop structure allows them to specifically bind to target sequences and produce detectable signals, serving as a mediator between the amplified DNA and the detection system, thereby simplifying the overall assay architecture.
2Reliability
If open hybridization format assays are used for Rifampicin-resistance screening, then detection capability is achieved, but ease of operation worsens due to requiring rigorous separation of work areas
Solution Approach 1:
The patent merges the amplification and detection steps into a single closed-tube PCR process. By using molecular beacon probes that remain contained within the PCR reaction vessel throughout the amplification process, the system eliminates the need to open the reaction for hybridization, thereby maintaining ease of operation while ensuring reliable detection.
Solution Approach 2:
The molecular beacon probes serve as intermediaries that enable detection within the closed PCR system. Their unique stem-loop structure allows them to bind specifically to target sequences during the PCR process and generate detectable signals without requiring the reaction tube to be opened, thus simplifying operational procedures while maintaining detection reliability.
3Measurement precision
If numerous probes are used to test for resistance-associated mutations, then measurement precision improves, but device complexity and assay chemistry complexity worsen
Solution Approach 1:
The patent applies local quality by designing molecular beacon probes with specific stem-loop structures tailored to detect particular mutation patterns. Each probe is locally optimized with a unique structure that confers specificity for certain mutations, allowing a smaller set of probes to achieve comprehensive coverage without requiring numerous individual probes for each possible mutation.
Solution Approach 2:
The molecular beacon probes exhibit multi-functionality by being capable of detecting multiple different resistance mutations through their designed stem-loop structures. A single probe can recognize and bind to various mutant sequences, thereby reducing the total number of probes needed while maintaining high measurement precision for mutation detection.
4Measurement precision
If numerous probes are used to test for resistance-associated mutations, then measurement precision improves, but assay chemistry complexity worsens
Solution Approach 1:
The patent employs local quality by optimizing the stem-loop structure of each molecular beacon probe to specifically recognize certain mutation patterns. This localized structural optimization allows the probes to achieve high measurement precision for detecting specific mutations without requiring complex chemistry formulations or multiple different probe types.
Solution Approach 2:
The molecular beacon probes demonstrate multi-functionality by being designed to detect multiple resistance mutations through their engineered stem-loop structures. This universal detection capability reduces the number of probes required and simplifies the overall assay chemistry, as fewer probe types need to be optimized and combined in the reaction mixture.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables a rapid, sensitive, and specific detection of Rifampicin-resistant M. tuberculosis with high reproducibility, capable of identifying various mutations, including both common and uncommon ones, and reduces the complexity of assay chemistry and hybridization parameters.
Implementation Method 1
probing the amplified nucleic acid with at least three molecular beacon probes for an RRDR mutant target
Implementation Method 2
conducting melting temperature (Tm) analysis to determine a Tm value for each probe
Data Source
AI summary
This invention relates to nucleic acids, reagents and methods for detecting Rifampicin-resistant Mycobacterium tuberculosis in a sample from a subject. In one aspect, the invention provides methods of detecting Rifampicin resistant M. tuberculosis in a sample comprising (a) amplifying a nucleic acid containing the rifampicin resistance determining region (RRDR) of the rpoB gene in a sample to provide an amplified nucleic acid; (b) probing the amplified nucleic acid with at least three molecular beacon probes for an RRDR mutant target; (c) conducting melting temperature (Tm) analysis to determine a Tm value for each probe; and (d) comparing the Tm value for each probe with a Tm value for a wild-type RRDR region, wherein a Tm value for at least one of the molecular beacon probes that is greater than the Tm value for the wild-type RRDR indicates the presence of rifampicin resistant M. tuberculosis in the sample.